Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective analysis of cell‐free DNA in maternal blood for evaluation of fetal trisomy

1 Jan 2012

Abstract excerpt

OBJECTIVE: To develop a novel prenatal assay based on selective analysis of cell-free DNA in maternal blood for evaluation of fetal Trisomy 21 (T21) and Trisomy 18 (T18). METHODS: Two hundred ninety-eight pregnancies, including 39 T21 and seven T18 confirmed fetal aneuploidies, were analyzed using a novel, highly multiplexed assay, termed digital analysis of selected regions (DANSR™). Cell-free DNA from maternal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22223233
DOI: 10.1002/pd.2922

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective analysis of cell‐free DNA in maternal blood for evaluation of fetal trisomyPMID 22223233Read ↗

Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18Semantic proximity Read ↗

Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studiesSemantic proximity Read ↗

Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnanciesSemantic proximity Read ↗

Non‐invasive prenatal testing for fetal aneuploidy: charting the course from clinical validity to clinical utilitySemantic proximity Read ↗

Feasibility Study of Semiconductor Sequencing for Noninvasive Prenatal Detection of Fetal AneuploidySemantic proximity Read ↗

Assessment of Fetal Sex Chromosome Aneuploidy Using Directed Cell-Free DNA AnalysisSemantic proximity Read ↗

Non-Invasive Prenatal Chromosomal Aneuploidy Testing - Clinical Experience: 100,000 Clinical SamplesSemantic proximity Read ↗

Clinical Experience of Non-Invasive Prenatal Chromosomal Aneuploidy Testing in 190,277 Patient SamplesSemantic proximity Read ↗

Non-invasive prenatal testing of fetal aneuploidies using a new method based on digital droplet PCR and cell free fetal DNASemantic proximity Read ↗

Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS studySemantic proximity Read ↗

Noninvasive prenatal detection of chromosomal aneuploidies using different next generation sequencing strategies and algorithmsSemantic proximity Read ↗

DNA Sequencing versus Standard Prenatal Aneuploidy ScreeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.